Anthropic starts IPO investor meetings, CNBC reports

Anthropic is arranging investor meetings as it prepares for a potential IPO later in 2025, signaling its share sale timeline could move quickly (rumored as soon as October). The AI firm filed a confidential IPO prospectus with the SEC last month and previously completed a $65B funding round at a $965B valuation in May, with Goldman Sachs, Morgan Stanley, and JPMorgan working on the deal. The preparations suggest investor demand is being tested ahead of a formal roadshow, which could support valuation momentum versus peers like OpenAI.

Analysis

The real signal is not the fee pool from one IPO; it is whether public markets will still underwrite frontier-AI narrative risk at near-unicorn prices. If investor meetings are strong, GS and MS gain a sequencing advantage into a broader 1-3 month reopening of late-stage tech issuance, which matters more for league-table momentum and ECM share than for near-term EPS. JPM benefits too, but structurally less, because its mix is more diversified and the incremental earnings leverage from a single AI listing is lower.

Second-order effects run beyond the banks. A successful bookbuild would validate a new financing path for private AI names that have been funding growth through venture rounds and structured capital; that can reduce the urgency of secondary sales and extend runway for other model builders. The flip side is that a weak reception would be a fast read-through on AI valuation fatigue, likely pressuring private-market marks across the ecosystem and cutting off follow-on issuance for months.

Catalyst timing matters: the next move is likely driven by filing/range talk and investor education, while the true test is the order book and how much of the story gets left on the table in pricing. Over 6-18 months, the more important question is whether public-market capital can absorb AI names without requiring a sharp reset in growth expectations; if not, this becomes a selective ECM event rather than a durable reopening. The contrarian risk is that the market is overestimating the durability of AI monetization versus the scarcity premium embedded in private rounds.

Key Decisions for Investors

• Tactically long GS/MS on a pullback into formal IPO launch or range-setting; this is a 1-3 month trade on ECM sentiment and league-table momentum, not a fundamental re-rating.
• Use GS/MS vs JPM as a relative-value pair: long GS/MS, short JPM or underweight JPM into a stronger AI-IPO pipeline, since GS/MS have higher operating leverage to underwriting and placements.
• Set a watch item on bookbuild quality and expected pricing discount to private valuation; if Anthropic clears close to the last round, increase confidence in a broader AI IPO reopening, but if pricing needs a steep cut, fade the bank-positive read-through.
• If the deal is pulled or materially downsized, expect negative spillover to private AI marks and late-stage growth comps; consider reducing exposure to AI/VC-sensitive baskets rather than adding risk.